1. Åkesson B, Jönsson BA (1997) Major metabolic pathway for N-methyl-2-pyrrolidone in humans. Drug Metabol Dispos 25:267–269
2. Boike GM, Deppe G, Young JD, Gove NL, Bottoms SF, Malone JM, Malviya VK, Sokol RJ (1989) Chemotherapy in a pregnant rat model. Gynecol Oncol 34:187–190
3. Byers JP, Sarver JG (2009) Pharmacokinetic modeling. In: Hacker MP, Messer WS, Bachmann KA (eds) Pharmacology. Principles and practice. Elsevier/Academic Press, Amsterdam, pp 201–277
4. Carnerup MA, Saillenfait AM, Jönsson BAG (2005) Concentrations of N-methyl-2-pyrrolidone (NMP) and its metabolites in plasma and urine following oral administration of NMP to rats. Food Chem Toxicol 43:1441–1447
5. Carpenter SP, Savage DD, Schultz ED, Raucy JL (1997) Ethanol-mediated transplacental induction of CYP2E1 in fetal rat liver. J Pharmacol Exp Therap 282:1028–1036